These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9329856)

  • 1. Transdermal progestins in hormone replacement therapy.
    Jasonni VM; Naldi S; Amadori A; Santini D; Ceccarelli C; Possati G; D'Anna R; Leonardi J
    Ann N Y Acad Sci; 1997 Sep; 828():352-7. PubMed ID: 9329856
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of transdermal estrogen without progestin increases the capacity of plasma and serum to stimulate prostacyclin production in human vascular endothelial cells.
    Mikkola T; Viinikka L; Ylikorkala O
    Fertil Steril; 2000 Jan; 73(1):72-4. PubMed ID: 10632415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
    Notelovitz M; Cassel D; Hille D; Furst KW; Dain MP; VandePol C; Skarinsky D
    Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):7-12. PubMed ID: 10649149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hormone replacement therapy on plasma glutathione S-transferase A1-1 concentrations in healthy postmenopausal women.
    Mulder TP; Knapen MF; van der Mooren MJ; Demacker PD; Roes EM; Steegers EA; Peters WH
    Clin Chem; 1998 Mar; 44(3):666-7. PubMed ID: 9510879
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Laivuori H; Koistinen HA; Karonen SL; Cacciatore B; Ylikorkala O
    Hum Reprod; 2001 Aug; 16(8):1632-5. PubMed ID: 11473954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
    Keller PJ; Hotz E; Imthurn B
    Maturitas; 1992 Dec; 15(3):195-8. PubMed ID: 1465033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal administration of oestrogen/progestagen hormone replacement therapy.
    Whitehead MI; Fraser D; Schenkel L; Crook D; Stevenson JC
    Lancet; 1990 Feb; 335(8685):310-2. PubMed ID: 1967769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
    Simsek T; Karakus C; Trak B
    Maturitas; 2002 Jul; 42(3):243-6. PubMed ID: 12161049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of norethisterone acetate on urinary urodilatin excretion in postmenopausal women.
    Mueck AO; Seeger H; Armbruster FP; Lippert TH
    Clin Exp Obstet Gynecol; 1998; 25(3):76-8. PubMed ID: 9856301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oral continuous and transdermal cyclic 17-beta estradiol and norethindrone acetate replacement therapy on platelet aggregation in postmenopausal women.
    Kaplan PB; Gücer F; Sayin NC; Yüce MA; Yardim T
    J Reprod Med; 2002 Aug; 47(8):651-5. PubMed ID: 12216432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.
    Bladbjerg EM; Skouby SO; Andersen LF; Jespersen J
    Hum Reprod; 2002 Dec; 17(12):3235-41. PubMed ID: 12456630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2.
    Viinikka L; Orpana A; Puolakka J; Pyörälä T; Ylikorkala O
    Obstet Gynecol; 1997 Jan; 89(1):104-7. PubMed ID: 8990448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
    Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
    Brosnan JF; Sheppard BL; Norris LA
    Thromb Haemost; 2007 Apr; 97(4):558-65. PubMed ID: 17393018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
    Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.